Tag Archives: DRIO

Top 10 Medical Stocks To Own Right Now

PerkinElmer, Inc. (PKI Quick QuotePKI ) is well-poised for growth, backed by a robust product portfolio and an impressive margin expansion. However, forex remains a concern.

Shares of this currently Zacks Rank #3 (Hold) stock have gained 27.2% compared with the industry’s growth of 21.6% in the past three months. The S&P 500 Index has rallied 5.1% in the same time frame.

PerkinElmer — with a market capitalization of $20.97 billion — offers scientific instruments, consumables and services to pharmaceutical, biomedical, environmental testing, chemical and general industrial markets worldwide. It anticipates earnings to improve 37.9% over the next five years. The company has a trailing four-quarter earnings surprise 24.3%, on average.

Key Catalysts

PerkinElmer delivers a comprehensive suite of scientific informatics and software solutions to aggregate data into actionable insights in an automated and scalable way.

Image Source: Zacks Investment Research

Top 10 Medical Stocks To Own Right Now: DarioHealth Corp. (DRIO)

DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company’s product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter. The Dario product is a digital diabetes management solution utilizing its technology delivered through a software application available for iPhone or Android and cloud-based data services with a blood glucose monitoring system device. Dario allows users to record, analyze, transmit and store various data points, such as glucose level, insulin and carbohydrate intake. It markets the Dario Smart Diabetes Management Solution in the Netherlands and New Zealand.
Advisors’ Opinion:

  • [By Max Byerly]

    Teleflex (NYSE:TFX) and DarioHealth (NASDAQ:DRIO) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, analyst recommendations, institutional ownership, profitability and risk.

  • [By Lisa Levin]

    DarioHealth Corp. (NASDAQ: DRIO) is projected to report quarterly loss at $0.19 per share on revenue of $1.74 million.

    CPI Aerostructures, Inc. (NYSE: CVU) is estimated to report quarterly earnings at $0.1 per share on revenue of $18.50 million.

Top 10 Medical Stocks To Own Right Now: Patriot National Bancorp Inc.(PNBK)

Patriot National Bancorp, Inc. operates as the bank holding company for Patriot National Bank that provides consumer and commercial banking services to individuals, small and medium-sized businesses, and professionals in Connecticut and New York. It offers various consumer and commercial deposit accounts, such as checking accounts, interest-bearing NOW accounts, insured money market accounts, time certificates of deposit, savings accounts, individual retirement accounts, and health savings accounts. The company also provides commercial loans, including secured and unsecured loans to service companies, real estate developers, manufacturers, restaurants, wholesalers, retailers, and professionals, as well as to small and medium-sized businesses; personal loans, such as lines of credit, installment loans, overdraft protection, and credit cards; real estate loans, including home mortgages, home improvement loans, bridge loans, home equity loans, and lines of credit to individua ls; and commercial real estate and construction loans to area businesses and developers. In addition, it offers Internet banking, bill paying, remote deposit capture, debit card, money order, traveler?s checks, and automated teller machine services; and solicits and processes mortgage loan applications from consumers on behalf of permanent investors and originates loans for sale. As of June 20, 2011, the company operated 15 full service branches, including 12 branches in Connecticut and 3 branches in New York, as well as a loan production office in Stamford, Connecticut. Patriot National Bancorp, Inc. was founded in 1994 and is headquartered in Stamford, Connecticut. Patriot National Bancorp Inc. is a subsidiary of PNBK Holdings LLC.

Advisors’ Opinion:

  • [By Max Byerly]

    Patriot National Bancorp (NASDAQ:PNBK) had its hold rating reaffirmed by analysts at Brean Capital.

    KeyCorp initiated coverage on shares of Republic Services (NYSE:RSG). KeyCorp issued a sector weight rating on the stock.

  • [By Logan Wallace]

    Patriot National Bancorp (NASDAQ:PNBK)’s stock had its “buy” rating reiterated by analysts at Brean Capital in a research report issued to clients and investors on Monday.

Top 10 Medical Stocks To Own Right Now: United States Cellular Corporation(USM)

United States Cellular Corporation operates as a wireless telecommunications service provider in the United States. The company offers wireless voice and data services to retail consumer and business customers. It provides wireless services in postpaid service plans with voice, messaging, and data services; and prepaid service plans with minutes, messaging, and data services for a monthly fee. The company also offers various additional features, including caller ID blocking, call forwarding, voicemail, call waiting, and three-way calling; and data usage features consisting of Web browsing, email services, instant messaging, text messaging, and picture and video messaging. As of December 31, 2010, it provided wireless voice and data services to 6.1 million customers in 26 states. In addition, the company operates retail stores that sell a range of wireless devices, including handsets, modems, and tablets, as well as accessories, such as carrying cases, hands-free devices, b atteries, battery chargers, memory cards, and other items to consumers and small businesses. Further, it sells wireless devices to agents and other third-party distributors for resale; operates service facilities that provide servicing and repair for wireless devices; and enables customers to activate service and purchase wireless devices online. The company?s business customers include small-to-mid-size businesses in various industries, including construction, retail, professional services, and real estate. It offers its products and services through retail sales and service centers, direct sales, and independent agents. The company was founded in 1983 and is based in Chicago, Illinois. United States Cellular Corporation is a subsidiary of Telephone and Data Systems, Inc.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    United States Cellular Corporation (NYSE:USM)Q42018 Earnings Conference CallFeb. 22, 2019, 10:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on United States Cellular (USM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    JPMorgan Chase & Co. raised its holdings in U.S. Cellular (NYSE:USM) by 770.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 52,229 shares of the Wireless communications provider’s stock after acquiring an additional 46,231 shares during the period. JPMorgan Chase & Co. owned about 0.06% of U.S. Cellular worth $2,099,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    These are some of the media stories that may have impacted Accern Sentiment Analysis’s analysis:

    Get U.S. Cellular alerts:

    $962.41 Million in Sales Expected for U.S. Cellular (USM) This Quarter (americanbankingnews.com) $0.21 Earnings Per Share Expected for U.S. Cellular (USM) This Quarter (americanbankingnews.com) OneNeck IT Solutions named to CRNs 2018 Solution Provider 500 list (prweb.com) U.S. Cellular Unveils Offers on iPhones With New Connections (zacks.com)

    USM has been the subject of several research analyst reports. Raymond James raised shares of U.S. Cellular from a “market perform” rating to an “outperform” rating in a research report on Wednesday, May 2nd. ValuEngine raised shares of U.S. Cellular from a “sell” rating to a “hold” rating in a research report on Monday, April 2nd. Finally, Zacks Investment Research raised shares of U.S. Cellular from a “hold” rating to a “buy” rating and set a $41.00 price objective for the company in a research report on Tuesday, February 27th.

Top 10 Medical Stocks To Own Right Now: Enzymotec Ltd.(ENZY )

Enzymotec Ltd. is a profitable nutritional ingredients and medical foods company. Our proprietary technologies, research expertise, and clinical validation process enable us to develop differentiated solutions across a variety of products. Our innovative and diverse product suite addresses the entire human life-cycle, from infancy to old age, and is comprised of novel key ingredients in products ranging from infant formula to nutritional supplements, as well as branded medical foods, sold only under a doctor’s supervision. We market our product portfolio to established global consumer companies and physicians and target large and growing consumer health and wellness markets. Our strategic partnerships, state-of-the-art good manufacturing practice (“GMP”)-compliant manufacturing facility, and global sales and marketing infrastructure enable us to develop, manufacture and market our comprehensive product solutions to our customers globally.   Advisors’ Opinion:

  • [By Logan Wallace]

    Press coverage about Enzymotec (NASDAQ:ENZY) has trended positive this week, Accern Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Enzymotec earned a coverage optimism score of 0.36 on Accern’s scale. Accern also assigned media headlines about the biotechnology company an impact score of 44.1639541610912 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Top 10 Medical Stocks To Own Right Now: Mackinac Financial Corporation(MFNC)

Mackinac Financial Corporation operates as the holding company for mBank that provides commercial and retail banking products and services. The company offers interest bearing and non-interest bearing deposit products, including commercial and retail checking accounts, negotiable order of withdrawal accounts, money market accounts, individual retirement accounts, regular interest-bearing statement savings accounts, and certificates of deposit. It also provides consumer loan products, such as installment, mortgages, and home equity loans, as well as residential mortgage loans, commercial and governmental lease financing, and direct and indirect consumer financing. In addition, the company offers title insurance services. It operates approximately 13 branch offices in the Upper Peninsula of Michigan and 4 branch offices in Michigans Lower Peninsula; and 20 automated teller machines. The company was formerly known as North Country Financial Corporation and changed its name to Mackinac Financial Corporation in December 2004. Mackinac Financial Corporation was incorporated in 1974 and is headquartered in Manistique, Michigan.

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Mackinac Financial (MFNC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    News headlines about Mackinac Financial (NASDAQ:MFNC) have trended somewhat positive this week, Accern reports. The research group identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Mackinac Financial earned a coverage optimism score of 0.07 on Accern’s scale. Accern also assigned news articles about the financial services provider an impact score of 46.7240712873041 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Medical Stocks To Own Right Now: Thor Industries Inc.(THO)

Thor Industries, Inc., together with its subsidiaries, manufactures and sells a range of recreation vehicles and small and mid-size buses, as well as related parts and accessories in the United States and Canada. The company offers a range of travel trailers and motorhomes under the trade name of Airstream, which include Airstream Safari, International, Flying Cloud, and Bambi travel trailers, as well as Interstate Class B motorhomes. It also manufactures and sells conventional travel trailers and fifth wheels under the trade names of Dutchmen, Four Winds, Aero, Grand Junction, Colorado, Cruiser, Seville, Zinger, and Sunset Trail; travel trailers and fifth wheels under trade names of Montana, Springdale, Hornet, Sprinter, Outback, Laredo, Everest, Mountaineer, Challenger, Cougar, Komfort, and Trailblazer; and gasoline and diesel Class C, Class A, and Class B motorhomes under the trade names of Four Winds, Hurricane, Windsport, Mandalay, Dutchmen, Chateau, Serrano, Ventura, and Fun Mover. In addition, it manufactures and sells gasoline and diesel Class A motor homes under the trade names of Daybreak, Challenger, Astoria, Tuscany, Outlaw, and Avanti; travel trailers, fifth wheels, truck campers, and park models under the trade name of General Coach; and park models under the trade names of Tranquility, Westchester, and Breckenridge. Further, the company manufactures small and mid-size transit and commercial buses under the trade names of Aerolite, AeroElite, Aerotech, Escort, MST, Transmark, EZ Rider, Axess, Challenger, Defender, Crusader, American Cruiser, Classic Coach, EZ Trans, GC II, and Pacer. It markets its vehicles through independent dealers to municipalities and private purchasers, such as rental car companies and hotels. The company has a joint venture agreement with Cruise America, Inc. to provide short-term rentals of motorized recreation vehicles to the public. Thor Industries was founded in 1980 and is based in Jackson Center, Oh io.

Advisors’ Opinion:

  • [By Rhian Hunt (TMFRhianHunt)]

    Recreational vehicle (RV) manufacturer Thor Industries (NYSE:THO) just announced its acquisition of RV parts maker AirX Intermediate, otherwise known as Airxcel. Thor, owner of famous RV brands like Airstream and Dutchmen, will pay $750 million for its new subsidiary. Investors responded positively, bidding up Thor’s stock more than 3% on Sept. 1, the day of the announcement. Here are three takeaways for investors.

  • [By Keith Noonan]

    Shares of LCI Industries(NYSE:LCII) lost 10.9% of their value in September, according to data fromS&P Global Market Intelligence. The stock fell after recreational-vehicle company Thor Industries(NYSE:THO) reported earnings results that had negative implications for LCI’s performance.

Top 10 Medical Stocks To Own Right Now: PagerDuty, Inc.(PD)

PagerDuty, Inc. operates a digital operations management platform in the United States and internationally. Its platform harnesses digital signals from virtually any software-enabled system or device, combines it with human response data, and orchestrates teams to take the right actions in real time. The company's platform provides on-call management, event intelligence, incident response, business visibility, and advanced analytics solutions to address digital operations management requirements. It serves various industries, including software and technology, telecommunications, retail, travel and hospitality, media and entertainment, and financial services. PagerDuty, Inc. was founded in 2009 and is headquartered in San Francisco, California.

Advisors’ Opinion:

  • [By Jeremy Bowman (tmfhobo)]

    Shares ofPagerDuty(NYSE:PD) were climbing today after the stock posted better-than-expected results in its second-quarter earnings report.

    As of 12:56 p.m. EDT on Friday, the stock was up 10.5%.

  • [By ]

    Shares of PagerDuty  (PD) – Get PagerDuty, Inc. Report advanced after the digital operations management platform reported a narrower-than-expected adjusted loss and issued a strong current-quarter revenue outlook. Revenue was $67.5 million, up 33% year over year.

  • [By Chris Hill]

    Rite Aid(NYSE:RAD) is probably a bit under the weather, if the one-for-20 stock split is any indication. News about Disney+ (NYSE:DIS) sent Disney shares soaring. Certain branches of Switzerland’s government has weird (read: bad) opinions about coffee. Uber’s S-1 left some big questions unanswered. PagerDuty(NYSE:PD) IPOed to thunderous applause, and Pinterest’s upcoming IPO is turning some heads. And, as always, the analysts share some stocks on their radars. Plus, Chris Hill talks with Motley Fool Singapore’s David Kuo about the other side of the U.S.-China trade war, the shifting landscape of Southeast Asian industry, why dividends are like Christmas every day, and more.

  • [By Logan Wallace]

    Wall Street brokerages expect Precision Drilling Corp (NYSE:PDS) (TSE:PD) to post $315.89 million in sales for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Precision Drilling’s earnings, with the lowest sales estimate coming in at $273.32 million and the highest estimate coming in at $358.42 million. Precision Drilling reported sales of $317.32 million during the same quarter last year, which indicates a negative year over year growth rate of 0.5%. The firm is expected to report its next earnings results on Thursday, April 25th.

Top 10 Medical Stocks To Own Right Now: Intercept Pharmaceuticals, Inc.(ICPT)

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. Its lead product candidate is obeticholic acid, a bile acid analog, that completed Phase III clinical trials for the treatment of primary biliary cholangitis and Phase II clinical trials for the treatment of nonalcoholic fatty liver disease; and is in Phase III clinical trials for the treatment of nonalcoholic steatohepatitis, Phase II clinical trials for the treatments of primary sclerosing cholangitis, and Phase II clinical trial for the treatment of biliary atresia. The company is also developing INT-767, an orally administered dual FXR and TGR5 agonist, which is in Phase I clinical trial for the treatment of fibrosis; and INT-777, an orally administered TGR5 agonist that is in preclinical stage for the treatment of type 2 diabetes. Intercept Pharmaceuticals, Inc. was founded in 2002 and is headquartered in New York, New York.

Advisors’ Opinion:

  • [By ]

    Shares of Intercept Pharmaceuticals  (ICPT) – Get Report slipped Friday after Goldman Sachs downgraded the biotech firm to sell from neutral and lowered its price target to $10 from $17.

  • [By George Budwell]

    Intercept Pharmaceuticals (NASDAQ:ICPT), a mid-cap drugmaker focusing on diseases of the liver, saw its shares lose 14.5% of their value last month,according to data fromS&P Global Market Intelligence. Prior to last month’s pullback, Intercept’s shares were up by almost 80% over the last 12 months.

  • [By Jon C. Ogg]

    Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) was last seen trading after the company’s financial reporting. While numbers are always important to see, a more subjective issue is a positive review from Wall Street.

  • [By Motley Fool Transcribing]

    Intercept Pharmaceuticals (NASDAQ:ICPT) Q4 2018 Earnings Conference CallFeb. 28, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Medical Stocks To Own Right Now: (LVMUY)

LVMH Mot Hennessy – Louis Vuitton SA engages in the manufacture and sale of luxury products. Its wine and spirits product line comprises champagne, sparkling and still wines, cognac, and other spirits primarily under the Mot & Chandon, Dom Prignon, Mercier, Ruinart, Veuve Clicquot, Krug, Chteau d?Yquem, Chteau Cheval Blanc, Hennessy, Glenmorangie, Ardbeg, and Belvedere brand names. The company offers fashion and leather goods consisting of trunks, leather goods, ready-to-wear, shoes, watches, jewelry, accessories, sunglasses, and books principally under the Louis Vuitton, Fendi, Donna Karan, Marc Jacobs, Loewe, Cline, Kenzo, Givenchy, Thomas Pink, Pucci, and Berluti brand names. Its perfumes and cosmetics product line includes fragrances, make-up, and skincare products under the Parfums Christian Dior, Guerlain, Parfums Givenchy, Kenzo Parfums, Fendi Parfums, Make Up For Ever, Parfums Loewe, Fresh, and Acqua di Parma brand names. The company also offers watche s and jewelry under the TAG Heuer, Hublot, Bulgari, Zenith, Montres Dior, De Beers, and Fred brand names. In addition, it operates retail stores under the brand names of DFS, Miami Cruiseline, Sephora, Samaritaine, and Le Bon March for travelers. As of December 31, 2011, the company operated 3,040 stores worldwide. LVMH Mot Hennessy – Louis Vuitton SA is based in Paris, France.

Advisors’ Opinion:

  • [By Leo Sun]

    LVMH (NASDAQOTH:LVMUY) is the world’s largest luxury company. Its sprawling portfolio of70 brands includes the fashion houses Louis Vuitton, Fendi, Christian Dior, Loewe, and Marc Jacobs; jewelry and watch brands like Bvlgari and Tag Heuer; retailers like Sephora and Le Bon March茅; and wine and spirit brands like Hennessy, Dom P茅rignon, and Mo毛t & Chandon. It sells its products at 4,590 stores across 70 countries.

  • [By Steve Symington]

    Shares of Tiffany & Co.(NYSE:TIF) were down 9% as of 2:30 p.m. EDT Wednesday following concerning comments on growth in Japan and China from fellow luxury goods specialist LVMH Moet Hennessy Louis Vuitton (NASDAQOTH:LVMUY). LVMH shares are also down 8% as of this writing.

  • [By Leo Sun]

    Second, Farfetch faces competition from a wide range of diversified online marketplaces and first-party direct-to-consumer channels. For example, LVMH (NASDAQOTH:LVMUY), the biggest luxury company in the world, recently launched 24 S猫vres, an online version of Paris’ high-end department store Le Bon March茅. 24 S猫vres offers personal shoppers viavideo chat, two-day free deliveries, and other perks.

  • [By ]

    Ferrari may be a carmaker but its valuation is more similar to those of luxury powerhouses like LVMH (OTCPK:LVMUY), Kering (OTCPK:PPRUY) or Richemont (OTCPK:CFRUY) than those of fellow car companies like former parent FCA or Germanys Daimler (OTCPK:DDAIF), BMW (OTCPK:BMWYY) or Volkswagen (OTCPK:VLKAY). No other automotive brand, luxury or volume, can compete with Ferrari’s operative EBIT margin of 22.69 percent and EBITDA margin of 30.3 percent for the full year 2017 (the runner-up being Volkswagen-owned Porsche with a margin of 17.6 percent for 2017). In my eyes, this is further proof of the fact that a Ferrari is not primarily a car but a luxury product. It just happens to be a luxury product that presents itself in the form of a car. The overwhelming majority of cars are purchased out of necessity. Even a premium product like a Mercedes-Benz or a BMW will in most cases remain a tool of transportation above everything else – although I could imagine that some of my fellow countrymen from Germany would fiercely disagree with me on this. No one, however, needs a Ferrari. Please note that I allow myself to exclude needs of the ego from my definition of necessity here. Still, Ferraris are in high demand. That is because customers dont buy them because they need but because they want them. It is this passion that ensures the companys success. It is noteworthy that at Ferrari revenue (+10 percent in 2017; +11.2 percent currency-adjusted) increases at a significantly faster pace than shipments (+4.8 percent in 2017) do. This underlines the business’s pricing power.

Top 10 Medical Stocks To Own Right Now: Washington Trust Bancorp, Inc.(WASH)

Washington Trust Bancorp, Inc. (the “Bancorp”), a publicly-owned registered bank holding company and financial holding company, was organized in 1984 under the laws of the state of Rhode Island. The Bancorp owns all of the outstanding common stock of The Washington Trust Company, of Westerly (the “Bank”), a Rhode Island chartered commercial bank founded in 1800. The Bancorp was formed in 1984 under a plan of reorganization in which outstanding common shares of the Bank were exchanged for common shares of the Bancorp. See additional information under the caption “Subsidiaries.   Advisors’ Opinion:

  • [By ]

    Deutsche Bank Aktiengesellschaft (NYSE:DB) and Washington Trust Bancorp (NASDAQ:WASH) are both finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk.

  • [By Shane Hupp]

    BidaskClub downgraded shares of Washington Trust Bancorp (NASDAQ:WASH) from a sell rating to a strong sell rating in a report published on Tuesday.

  • [By Stephan Byrd]

    Shares of Washington Trust Bancorp (NASDAQ:WASH) hit a new 52-week high and low during trading on Friday . The company traded as low as $60.60 and last traded at $60.15, with a volume of 256 shares traded. The stock had previously closed at $60.15.

Top 5 Medical Stocks To Watch Right Now

General Electric CEO Jeffrey Immelt said his company can succeed without favorable trade deals because of its strategy of building products where it sells them.

GE is insulated from the prospect of increasing tariffs and trade obstacles “because we have a superior global footprint,” Immelt told investors in an annual letter.

As President Trump threatens a border tax for goods built on foreign soil and sold to Americans, major manufacturers are scrambling to limit the implications for their industry.

Many have emphasized their reliance on manufacturing goods in local markets instead of exporting to foreign countries, which limits exposure to fluctuating currency rates and reduces transportation costs.

“We will adjust to potential changes in tax policy or protectionist tendencies,” Immelt said. “We see many giving up on globalization; that means more for us.”

Top 5 Medical Stocks To Watch Right Now: iShares Mortgage Real Estate Capped (REM)

iShares Mortgage Real Estate Capped ETF, formerly iShares FTSE NAREIT Mortgage Plus Capped Index Fund (the Fund), is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the FTSE NAREIT All Mortgage Capped Index (the Index). The Index measures the performance of the residential and commercial mortgage real estate, mortgage finance and savings associations sectors of the United States equity market. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund’s investment advisor is BlackRock Fund Advisors.
Advisors’ Opinion:

  • [By Stephan Byrd]

    Remme (REM) is a token. It launched on December 4th, 2017. Remme’s total supply is 1,000,000,000 tokens and its circulating supply is 614,315,410 tokens. Remme’s official Twitter account is @remme_io and its Facebook page is accessible here. The Reddit community for Remme is /r/remme and the currency’s Github account can be viewed here. The official website for Remme is remme.io. The official message board for Remme is medium.com/remme.

  • [By Ethan Ryder]

    Remme (CURRENCY:REM) traded 1.4% higher against the U.S. dollar during the twenty-four hour period ending at 22:00 PM E.T. on August 31st. Remme has a market cap of $4.00 million and $344,172.00 worth of Remme was traded on exchanges in the last 24 hours. One Remme token can now be bought for $0.0066 or 0.00000094 BTC on major exchanges including Tidex, Kuna, DEx.top and Gate.io. During the last seven days, Remme has traded up 7.7% against the U.S. dollar.

Top 5 Medical Stocks To Watch Right Now: DarioHealth Corp. (DRIO)

DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company’s product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter. The Dario product is a digital diabetes management solution utilizing its technology delivered through a software application available for iPhone or Android and cloud-based data services with a blood glucose monitoring system device. Dario allows users to record, analyze, transmit and store various data points, such as glucose level, insulin and carbohydrate intake. It markets the Dario Smart Diabetes Management Solution in the Netherlands and New Zealand.
Advisors’ Opinion:

  • [By Max Byerly]

    Teleflex (NYSE:TFX) and DarioHealth (NASDAQ:DRIO) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, analyst recommendations, institutional ownership, profitability and risk.

  • [By Lisa Levin]

    DarioHealth Corp. (NASDAQ: DRIO) is projected to report quarterly loss at $0.19 per share on revenue of $1.74 million.

    CPI Aerostructures, Inc. (NYSE: CVU) is estimated to report quarterly earnings at $0.1 per share on revenue of $18.50 million.

Top 5 Medical Stocks To Watch Right Now: CIENA Corporation(CIEN)

Ciena Corporation provides equipment, software, and service solutions that support the transport, switching, aggregation, and management of voice, video, and data traffic on communications networks worldwide. Its product portfolio consists of packet-optical transport that includes optical transport solutions to increase network capacity and enable delivery of a broader mix of high-bandwidth services; and packet-optical switching, which comprise optical switching platforms incorporating multiservice and multi-protocol switching systems that enable automated optical infrastructures for the delivery of various enterprise and consumer-oriented network services. The company also offers carrier Ethernet solutions, including service delivery switches and service aggregation switches to support the access and aggregation tiers of communications networks, as well as to support wireless backhaul infrastructures and business data services; and software solutions to track individual s ervices across multiple product suites, facilitating planned network maintenance, outage detection, and identification of customers or services affected by network troubles. In addition, Ciena Corporation provides consulting and support services, such as project management, deployment, maintenance support, consulting, and training services, as well as network analysis, planning, design, optimization, and tuning. Its packet-optical transport, packet-optical switching, and carrier Ethernet solutions products are used individually or as part of an integrated solution in communications networks operated by communications service providers, cable operators, governments, enterprises, and other network operators. The company sells its communications networking solutions directly, as well as through strategic channel relationships. Ciena Corporation was founded in 1992 and is headquartered in Linthicum, Maryland.

Advisors’ Opinion:

  • [By Joseph Griffin]

    Ciena Co. (NYSE:CIEN) – Stock analysts at Jefferies Financial Group lowered their Q3 2019 earnings per share estimates for Ciena in a research note issued to investors on Wednesday, March 6th. Jefferies Financial Group analyst G. Notter now expects that the communications equipment provider will post earnings per share of $0.45 for the quarter, down from their previous forecast of $0.46. Jefferies Financial Group currently has a “Buy” rating and a $45.00 target price on the stock. Jefferies Financial Group also issued estimates for Ciena’s Q4 2019 earnings at $0.50 EPS, Q4 2020 earnings at $0.66 EPS and Q1 2021 earnings at $0.52 EPS.

  • [By Garrett Baldwin]

    Click here now.

    Stocks to Watch Today: TGT, CRM, FB
    This morning, shares of Target Corp. (NYSE: TGT) popped nearly 6% after a strong Q4 earnings report. The company reported earnings per share of $1.53 on total revenue of $22.98 billion. Wall Street expected $1.52 per share on sales of $22.91 billion. The firm reported very strong online sales (up 25%) and a 5.3% jump in same-store sales. Analysts had expected a 4.5% increase in same-store sales. The report is the latest sign that Target has emerged as a formidable competitor to Amazon.com Inc. (NASDAQ: AMZN) and Walmart Inc. (NYSE: WMT). Facebook Inc. (NASDAQ: FB) is under fire again due to security concerns around its sign-in features. The company has not allowed users to opt out of the key feature that lets users look up others by phone number and e-mail address. Many people have added their phone numbers in the past thinking it would only be used for two-factor authentication and security. Critics argue this is the latest episode of Facebook compromising user information. Shares of Salesforce.com Inc. (NYSE: CRM) are in focus as the cloud computing giant plans to report earnings after the bell Tuesday. CRM stock is already up 20% so far this year. And many analysts expect the firm to report earnings per share of $0.55 on top of $3.56 billion in revenue. Yesterday, Salesforce co-CEO Marc Benioff predicted that $30 billion in annual revenue for the cloud computing giant is “right around the corner.” Look for earnings reports from AeroVironment Inc. (NASDAQ: AVAV), Ambarella Inc. (NASDAQ: AMBA), Ciena Corp. (NASDAQ: CIEN), Kohl’s Corp. (NYSE: KSS), Ross Stores Inc. (NASDAQ: ROST), Sina Corp. (NASDAQ: SINA), Urban Outfitters Inc. (NASDAQ: URBN), Vivint Solar Inc. (NASDAQ: VSLR), and Weibo Corp. (NYSE: WB).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

Top 5 Medical Stocks To Watch Right Now: Daxor Corporation(DXR)

Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
    Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
    Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
    RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
    Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
    Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
    Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
    CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering

  • [By Logan Wallace]

    Daxor Co. (NYSEAMERICAN:DXR) saw a significant growth in short interest in the month of March. As of March 29th, there was short interest totalling 234,045 shares, a growth of 1,257.4% from the March 15th total of 17,242 shares. Based on an average daily trading volume, of 1,214,477 shares, the days-to-cover ratio is presently 0.2 days. Currently, 33.3% of the company’s shares are short sold.

Top 5 Medical Stocks To Watch Right Now: Clear Channel Outdoor Holdings, Inc.(CCO)

Clear Channel Outdoor Holdings, Inc., an outdoor advertising company, owns and operates advertising display faces worldwide. It operates in two segments, Americas and International. The company offers advertising services through billboards comprising bulletins and posters; street furniture displays, including advertising surfaces on bus shelters, information kiosks, freestanding units, and other public structures; transit displays, which are advertising surfaces on various types of vehicles or within transit systems; and other out-of-home advertising displays, such as wallscapes and spectaculars, as well as mall displays. It also operates SmartBike bicycle rental program, which provides bicycles for rent to the general public in various municipalities; and sells street furniture equipment, as well as provides cleaning and maintenance, and production and creative services. Clear Channel Outdoor Holdings, Inc. serves the retail, business services, media, healthcare and medical, banking and financial services, food and food products, entertainment, telecommunications and automotive, accessories, and equipment industries. As of December 31, 2015, it owned and operated approximately 650,000 advertising displays. The company was formerly known as Eller Media Company and changed its name to Clear Channel Outdoor Holdings, Inc. in August 2005. Clear Channel Outdoor Holdings, Inc. was incorporated in 1995 and is headquartered in San Antonio, Texas. Clear Channel Outdoor Holdings, Inc. is a subsidiary of iHeartCommunications, Inc.

Advisors’ Opinion:

  • [By Shane Hupp]

    Ccore (CURRENCY:CCO) traded down 19.1% against the U.S. dollar during the 1-day period ending at 13:00 PM ET on March 12th. Ccore has a market capitalization of $27,097.00 and approximately $9.00 worth of Ccore was traded on exchanges in the last 24 hours. Over the last week, Ccore has traded down 15.9% against the U.S. dollar. One Ccore token can now be bought for approximately $0.0159 or 0.00000408 BTC on exchanges including IDEX and Mercatox.

  • [By Motley Fool Transcribers]

    Clear Channel Outdoor Holdings Inc  (NYSE:CCO)Q4 2018 Earnings Conference CallMarch 05, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Ccore (CURRENCY:CCO) traded up 77.5% against the dollar during the 24-hour period ending at 13:00 PM ET on October 1st. Ccore has a total market cap of $131,576.00 and approximately $9.00 worth of Ccore was traded on exchanges in the last day. Over the last week, Ccore has traded 53.5% lower against the dollar. One Ccore token can currently be purchased for about $0.0774 or 0.00001179 BTC on major cryptocurrency exchanges including IDEX and Mercatox.

  • [By Ethan Ryder]

    Ccore (CURRENCY:CCO) traded up 9.7% against the US dollar during the twenty-four hour period ending at 7:00 AM E.T. on September 21st. One Ccore token can currently be purchased for approximately $0.12 or 0.00001753 BTC on major cryptocurrency exchanges including IDEX and Mercatox. In the last seven days, Ccore has traded up 9% against the US dollar. Ccore has a total market capitalization of $200,532.00 and $142.00 worth of Ccore was traded on exchanges in the last day.